Jun Yan
Director/Board Member at JIANGSU SHENTONG VALVE CO., LTD.
Profile
Jun Yan currently works at Jiangsu Shentong Valve Co., Ltd., as Independent Director from 2019, Shanghai Allist Pharmaceuticals Co., Ltd., as Independent Director from 2019, and Shanghai Haihe Biopharma Co., Ltd., as Independent Director from 2020.
Mr. Yan also formerly worked at Wenfeng Great World Chain Development Corp., as Independent Director.
Mr. Yan received his undergraduate degree from Fudan University.
Jun Yan active positions
| Companies | Position | Start |
|---|---|---|
| JIANGSU SHENTONG VALVE CO., LTD. | Director/Board Member | 2019-07-24 |
| SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Director/Board Member | 2019-11-27 |
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Director/Board Member | 2020-09-07 |
Former positions of Jun Yan
| Companies | Position | End |
|---|---|---|
| WENFENG GREAT WORLD CHAIN DEVELOPMENT CORPORATION | Director/Board Member | - |
Training of Jun Yan
| Fudan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| JIANGSU SHENTONG VALVE CO., LTD. | Producer Manufacturing |
| WENFENG GREAT WORLD CHAIN DEVELOPMENT CORPORATION | Retail Trade |
| SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
- Stock Market
- Insiders
- Jun Yan
